Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Over the past month, shares of this medical device maker have returned +3.5%, compared to the Zacks S&P 500 composite's +0.9% change. During this period, the Zacks Medical - Instruments industry, which Hologic falls in, has gained 3.1%. The key question now is: What could be the stock's future direction?Although medi ...

Hologic 盈利表现 - Hologic (HOLX) 是一家在 Zacks Medical - Instruments 行业中表现出潜力的公司，过去两个季度的平均盈利惊喜率为5.19%[1],[2] - 在上个季度，Hologic 的盈利为每股0.89美元，超出了Zacks Consensus Estimate的0.85美元，盈利惊喜率为4.71%[3] - 在前一个季度，公司预计每股盈利为0.88美元，实际盈利为0.93美元，盈利惊喜率为5.68%[3] Hologic 未来盈利预期 - Hologic 的盈利预期一直呈上升趋势，部分归功于其盈利惊喜历史[4] - Hologic 目前的Earnings ESP为+2.88%，表明分析师对其近期盈利潜力持乐观态度[7] 投资建议 - 结合股票的正面Zacks Earnings ESP和稳健的Zacks Rank，显示未来盈利可能会超出预期[4],[5] - 当Earnings ESP为负值时，投资者应注意这会降低该指标的预测能力[8] - 在公司季度发布财报之前检查其Earnings ESP非常重要，以增加成功的几率[10]

The U.S. fell seven places in an annual global ranking of women’s health, landing at 30th place alongside Kazakhstan and Mauritius. The health index, created by women’s health innovation company Hologic Inc. HOLX in partnership with Gallup, found that the world “faces an emergency in women’s health” as billions of women are going untested for potentially life-threatening conditions. Women’s emotional health has also worsened since the height of the pandemic, according to the latest index, which is now i ...

DAVOS, Switzerland--(BUSINESS WIRE)--The world faces an emergency in women’s health even as the COVID-19 pandemic wanes, according to one of the largest annual updates on women’s well-being — the Hologic Global Women’s Health Index. Women’s health innovation company Hologic, Inc. (Nasdaq: HOLX) partners with Gallup to create the Index, which in its third year shows that billions of women are not getting tested for potentially life-threatening conditions. The Index also shows that more women are sad, angr ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced its new uterine health education and awareness campaign Better is Possible™. Launching in New York, Los Angeles, Atlanta and Detroit, the campaign seeks to increase awareness about daily quality-of-life challenges such as heavy and disruptive periods, pelvic pain and fibroids, while also educating women about available treatment options. Heavy and disruptive periods, also known as abnorma ...

Hologic (HOLX) closed the most recent trading day at $72.12, moving +1.11% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.15%. Elsewhere, the Dow saw a downswing of 0.42%, while the tech-heavy Nasdaq appreciated by 0.09%.Prior to today's trading, shares of the medical device maker had gained 3.86% over the past month. This has lagged the Medical sector's gain of 6.58% and outpaced the S&P 500's gain of 3.5% in that time.Market participants will be close ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this medical device maker have returned +6.7% over the past month versus the Zacks S&P 500 composite's +2.9% change. The Zacks Medical - Instruments industry, to which Hologic belongs, has gained 6.1% over this period. Now the key question is: Where could the stock be headed in the near term?Although media ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30, 2023. The Company expects to report total revenues of approximately $1,013.1 million, a decrease of (5.7%) compared to the prior year period, or (6.4%) in constant currency. These preliminary results exceed the Company’s most recent revenue guidance range of $960 to $985 million, provided on November 9, 2023. “Once again we delivered strong organic ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2024 on Thursday, February 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (888) 394-8218 (in the United States and Canada) or +1 (773) 305-6853 (for international callers) and referencing access ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time. The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event. About Hologic, Inc. Hologic, Inc. is an innovative medica ...